ELVN Enliven Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$46.97
· of 52w range
· above low
· to high
$14.7952w low
$62.3252w high
Market Cap (MRQ)
$3.44B
P/E
-25.7
EPS
$-1.83
your badges
52W Range
$15–$62
Analyst Rating
BUY
Price Target
$74
P/E
-25.7
ROE
-21.9%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ELVN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$46.97
Market Cap (MRQ)
$3.44B
P/E
-25.7
EPS
$-1.83
ROE
-21.9%
52W Range
$15–$62
ELVN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.832021-12-31 → 2025-12-31
Free Cash Flow$-70M2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ELVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -25.75Y avg ≈-6.5 | ≈-6.5 | · | · | |
| P/B (MRQ) | 3.85Y avg ≈3.1 | ≈3.1 | 7.2 | Undervalued | |
| Price / FCF (TTM) | -51.35Y avg ≈-10.9 | ≈-10.9 | · | · | |
| Price / Cash Flow (TTM) | -51.45Y avg ≈-10.9 | ≈-10.9 | · | · | |
| Price / Tangible Book | 6.15Y avg ≈2.6 | ≈2.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ELVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -25.9%5Y avg ≈-30.0% | ≈-30.0% | -12.8% | Weak | |
| ROE | -21.9%5Y avg ≈-24.3% | ≈-24.3% | -20.8% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ELVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 64.15Y avg ≈24.2 | ≈24.2 | 7.7 | Strong liquidity | |
| Quick Ratio | 27.95Y avg ≈22.5 | ≈22.5 | 2.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.21%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 19, 2026 | $-0.49 | $-0.41 | -20.6% |
| March 31, 2026 | May 20, 2026 | $-0.38 | $-0.47 | 19.5% |
| Dec. 31, 2025 | $-0.48 | $-0.39 | -24.6% | |
| Sept. 30, 2025 | $-0.32 | $-0.44 | 27.7% | |
| June 30, 2025 | $-0.49 | $-0.54 | 10.0% | |
| March 31, 2025 | $-0.57 | $-0.51 | -10.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $86M | $81M | $65M | $31M | $38M | $32M | $19M | |
| SG&A Expense | $34M | $24M | $19M | $8M | $13M | $10M | $5M | |
| Operating Expenses | $120M | $105M | $84M | $39M | $51M | $42M | $24M | |
| Operating Income | $-120M | $-105M | $-84M | $-39M | $-51M | $-42M | $-24M | |
| Other Non-op | $-49.0K | $-2.0K | $-22.0K | $0 | $-175.0K | $-145.0K | $75.0K | |
| Pretax Income | · | · | · | $2M | $-51M | · | · | |
| Income Tax | $0 | $232.0K | $0 | $0 | · | · | · | |
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | $-23M | |
| EPS (Basic) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| EPS (Diluted) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| Shares (Basic) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| Shares (Diluted) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| EBITDA | $-119M | $-104M | $-83M | $730.0K | $-51M | $-42M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $124M | $100M | $76M | $48M | $48M | $5M | |
| Short-term Investments | $364M | $189M | $153M | $0 | · | · | · | |
| Prepaid Expense | $12M | $5M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $475M | $318M | $266M | $78M | $93M | $90M | $31M | |
| PP&E (Net) | $34.0K | $458.0K | $742.0K | $890.0K | $250.0K | $349.0K | $442.0K | |
| PP&E (Gross) | $263.0K | $1M | $1M | $1M | $479.0K | $479.0K | $475.0K | |
| Accum. Depreciation | $229.0K | $919.0K | $671.0K | $374.0K | $229.0K | $130.0K | $33.0K | |
| Other Non-current Assets | $656.0K | $7M | $4M | $0 | $175.0K | $88.0K | $2M | |
| Total Assets | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Accounts Payable | $2M | $1M | $532.0K | $3M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | $2M | $5M | $4M | $3M | |
| Current Liabilities | $17M | $16M | $26M | $10M | $7M | $6M | $4M | |
| Capital Leases | $0 | · | $0 | · | $406.0K | · | · | |
| Other Non-current Liabilities | $0 | $0 | $67.0K | $659.0K | · | · | · | |
| Total Liabilities | $17M | $16M | $26M | $10M | $8M | $6M | $4M | |
| Common Stock | $59.0K | $49.0K | $41.0K | $1.0K | $27.0K | $18.0K | $1.0K | |
| Paid-in Capital | $806M | $553M | $400M | $6M | $234M | $181M | $6M | |
| Retained Earnings | $-347M | $-243M | $-154M | $-83M | $-147M | $-96M | $-55M | |
| AOCI | $334.0K | $55.0K | $141.0K | $0 | $-16.0K | $4.0K | $32.0K | |
| Stockholders' Equity | $460M | $310M | $246M | $-77M | $-43M | $84M | $-49M | |
| Liabilities + Equity | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Shares Outstanding | 59,440,045 | 48,936,459 | 41,292,027 | 3,570,019 | 26,287,264 | 17,548,263 | 702,510 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $300.0K | $200.0K | · | · | · | |
| Stock-based Comp | $34M | $20M | $13M | $3M | $4M | $2M | $899.0K | |
| Other Non-cash | $-926.0K | $-5M | $-3M | · | · | · | · | |
| Operating Cash Flow | $-70M | $-73M | $-61M | $-32M | $-47M | $-37M | $-22M | |
| CapEx | $158.0K | $44.0K | $149.0K | $612.0K | $12.0K | $18.0K | $140.0K | |
| Investing Cash Flow | $-174M | $-36M | $-148M | $-612.0K | $-2M | $-17M | $-24M | |
| Stock Issued | · | $0 | $161M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $161M | · | · | · | · | |
| Financing Cash Flow | $219M | $133M | $234M | $-2M | $49M | $97M | $44M | |
| Taxes Paid | $0 | $209.0K | · | · | · | · | · | |
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M | $-37M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -25.9% | -29.8% | -40.3% | 1.6% | -55.7% | -66.6% | · | |
| ROE | -21.9% | -29.8% | -28.2% | 13.5% | -55.4% | -46.2% | · | |
| ROIC | · | · | · | 0.76% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 | 14.5 | · | |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 | 7.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.73 | $6.33 | $5.96 | $3.43 | $3.27 | $4.81 | · | |
| Cash Flow / Share | $-1.24 | $-1.55 | $-1.72 | $-1.35 | · | · | · | |
| Cash / Share | $1.66 | $2.54 | $2.43 | $3.36 | $1.84 | $2.72 | · | |
| EPS (TTM) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | · | |
| Market Cap | $915M | $1.10B | $571M | $430M | $237M | $1.55B | · | |
| P/E | -8.4 | -11.9 | -6.9 | -1.4 | -3.8 | · | · | |
| P/B | 2.0 | 3.6 | 2.3 | 4.8 | 2.8 | 18.3 | · | |
| P / Tangible Book | 2.0 | 3.6 | 2.3 | · | · | 18.3 | · | |
| P / Cash Flow | -13.0 | -15.0 | -9.3 | -12.1 | -5.1 | -41.4 | · | |
| P / FCF | -13.0 | -15.0 | -9.3 | -12.0 | -5.1 | -41.4 | · | |
| Earnings Yield | -11.9% | -8.4% | -14.5% | -73.7% | -26.3% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $21M | $21M | $18M | $21M | $25M | $21M | $21M | $19M | $20M | $18M | $20M | $15M | $12M | $8M | $8M | |
| SG&A Expense | $8M | $7M | $13M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $2M | $3M | |
| Operating Expenses | $37M | $28M | $34M | $25M | $29M | $32M | $27M | $27M | $25M | $26M | $23M | $24M | $20M | $16M | $10M | $11M | |
| Operating Income | $-37M | $-28M | $-34M | $-25M | $-29M | $-32M | $-27M | $-27M | $-25M | $-26M | $-23M | $-24M | $-20M | $-16M | $-10M | $-11M | |
| Other Non-op | $-8.0K | $0 | $0 | $0 | $-2.0K | $-47.0K | $0 | $0 | $-1.0K | $-1.0K | $-9.0K | $-13.0K | $0 | $0 | $-136.0K | $0 | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $232.0K | · | $0 | $0 | · | · | · | · | |
| Net Income | $-32M | $-24M | $-30M | $-20M | $-25M | $-29M | $-23M | $-23M | $-20M | $-23M | $-19M | $-21M | $-17M | $-15M | $-10M | $-11M | |
| EPS (Basic) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| EPS (Diluted) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| Shares (Basic) | 66,171,581 | 62,799,326 | · | 62,093,795 | 52,105,052 | 50,051,283 | · | 48,267,458 | 48,075,035 | 42,045,608 | · | 41,030,874 | 40,961,024 | 40,961,024 | · | 3,228,692 | |
| Shares (Diluted) | 66,171,581 | 62,799,326 | · | 62,093,795 | 52,105,052 | 50,051,283 | · | 48,267,458 | 48,075,035 | 42,045,608 | · | 41,030,874 | 40,961,024 | 40,961,024 | · | 3,228,692 | |
| EBITDA | $-37M | $-28M | · | $-25M | $-29M | $-32M | · | $-27M | $-25M | $-26M | · | $-24M | $-20M | $51M | · | $-5M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $132M | $99M | $102M | $119M | $102M | $124M | $101M | $97M | $149M | $100M | $74M | $126M | $292M | $76M | $49M | |
| Short-term Investments | $760M | $320M | $364M | $376M | $371M | $188M | $189M | $191M | $216M | $171M | $153M | $190M | $152M | · | $0 | · | |
| Prepaid Expense | $12M | $11M | $12M | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $3M | $5M | $5M | $6M | $2M | $3M | |
| Current Assets | $907M | $463M | $475M | $483M | $496M | $294M | $318M | $297M | $318M | $337M | $266M | $269M | $283M | $298M | $78M | $59M | |
| PP&E (Net) | $140.0K | $20.0K | $34.0K | $399.0K | $462.0K | $404.0K | $458.0K | $549.0K | $630.0K | $683.0K | $742.0K | $806.0K | $867.0K | $853.0K | $890.0K | · | |
| PP&E (Gross) | $390.0K | · | $263.0K | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| Accum. Depreciation | $250.0K | $243.0K | $229.0K | $1M | $1M | $993.0K | $919.0K | $908.0K | $828.0K | $750.0K | $671.0K | $593.0K | $515.0K | $441.0K | $374.0K | · | |
| Other Non-current Assets | $1M | $1M | $656.0K | $7M | $7M | $7M | $7M | $7M | $8M | $4M | $4M | $4M | $3M | $3M | $0 | · | |
| Total Assets | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Accounts Payable | $371.0K | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $3M | $532.0K | $1M | $3M | $6M | $3M | $767.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $14M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $9M | $11M | $10M | $2M | |
| Capital Leases | $913.0K | $0 | $0 | $103.0K | $204.0K | $302.0K | · | $0 | $0 | $0 | · | $81.0K | $162.0K | $242.0K | · | · | |
| Other Non-current Liabilities | $913.0K | · | · | $103.0K | $204.0K | $302.0K | · | $0 | $6.0K | $34.0K | $67.0K | $214.0K | $360.0K | $508.0K | $659.0K | · | |
| Total Liabilities | $15M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $10M | $11M | $10M | $2M | |
| Common Stock | $73.0K | $61.0K | $59.0K | $59.0K | $59.0K | $49.0K | $49.0K | $47.0K | $47.0K | $47.0K | $41.0K | $41.0K | $41.0K | $41.0K | $1.0K | $27.0K | |
| Paid-in Capital | $1.30B | $824M | $806M | $793M | $786M | $560M | $553M | $508M | $502M | $495M | $400M | $397M | $393M | $389M | $6M | $235M | |
| Retained Earnings | $-403M | $-371M | $-347M | $-317M | $-297M | $-272M | $-243M | $-220M | $-197M | $-177M | $-154M | $-135M | $-114M | $-98M | $-83M | $-178M | |
| AOCI | $-2M | $-382.0K | $334.0K | $221.0K | $-177.0K | $-16.0K | $55.0K | $242.0K | $-139.0K | $-53.0K | $141.0K | $-147.0K | $-111.0K | · | $0 | $-4.0K | |
| Stockholders' Equity | $895M | $453M | $460M | $476M | $488M | $288M | $310M | $288M | $305M | $318M | $246M | $262M | $279M | $291M | $-77M | $57M | |
| Liabilities + Equity | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Shares Outstanding | 73,251,648 | 60,889,655 | 59,440,045 | 59,261,286 | 59,226,171 | 49,038,730 | 48,936,459 | 47,254,280 | 47,173,466 | 46,782,639 | 41,292,027 | 41,204,973 | 41,151,111 | 41,106,277 | 3,570,019 | 26,287,264 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.0K | $14.0K | $83.0K | $62.0K | $81.0K | $74.0K | $62.0K | $80.0K | $79.0K | $79.0K | $80.0K | $79.0K | $74.0K | $67.0K | $-39M | $60.0K | |
| Stock-based Comp | $14M | $7M | $12M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | $3M | $4M | $2M | $735.0K | $1M | |
| Other Non-cash | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · | · | $-75M | · | · | |
| Operating Cash Flow | $-19M | $-19M | $-16M | $-13M | $-17M | $-24M | $-17M | $-12M | $-20M | $-23M | $-12M | $-16M | $-12M | $-21M | $-8M | $6M | |
| CapEx | $99.0K | $0 | $0 | $-1.0K | $139.0K | $20.0K | $0 | $22.0K | $2.0K | $20.0K | $14.0K | $16.0K | $88.0K | $31.0K | $101.0K | $169.0K | |
| Investing Cash Flow | $-442M | $43M | $12M | $-4M | $-184M | $1M | $727.0K | $15M | $-34M | $-18M | $39M | $-36M | $-152M | $-31.0K | $-101.0K | $-12M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-2M | $163M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $163M | · | · | |
| Financing Cash Flow | $463M | $10M | $623.0K | $-368.0K | $218M | $234.0K | $40M | $1M | $2M | $90M | $90.0K | $-425.0K | $-3M | $237M | $-2M | $164.0K | |
| Taxes Paid | · | · | $0 | · | · | · | $-23.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-19M | · | · | · | $-24M | · | · | · | $-23M | · | · | · | $-21M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -4.6% | -6.2% | · | -5.1% | -6.1% | -8.8% | · | -8.0% | -6.5% | -7.0% | · | -12.5% | -9.5% | -7.7% | · | -5.5% | |
| ROE | -4.7% | -6.4% | · | -5.3% | -6.4% | -9.4% | · | -8.4% | -6.8% | -7.5% | · | -13.0% | -9.8% | -8.1% | · | -5.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 64.1 | 40.3 | · | 32.9 | 32.6 | 21.1 | · | 17.4 | 14.4 | 13.5 | · | 22.2 | 31.0 | 27.2 | · | 32.5 | |
| Quick Ratio | 63.2 | 39.4 | · | 32.6 | 32.2 | 20.7 | · | 17.1 | 14.1 | 12.8 | · | 21.8 | 30.4 | 26.7 | · | 27.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.22 | $7.45 | · | $8.03 | $8.25 | $5.88 | · | $6.10 | $6.46 | $6.79 | · | $6.35 | $6.78 | $7.09 | · | $2.18 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.48 | · | · | · | $-0.56 | · | · | · | $-1.13 | · | · | |
| Cash / Share | $1.85 | $2.17 | · | $1.72 | $2.02 | $2.07 | · | $2.13 | $2.05 | $3.19 | · | $1.79 | $3.06 | $7.11 | · | $1.88 | |
| EPS (TTM) | $-1.64 | $-1.64 | · | $-1.84 | $-2.00 | $-1.92 | · | $-1.72 | $-1.75 | $-1.75 | · | $-4.63 | $-7.39 | $-9.84 | · | $-10.18 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-106M | $-99M | · | $-97M | $-100M | $-95M | · | $-85M | $-83M | $-80M | · | $-62M | $-52M | $-44M | · | $-42M | |
| Market Cap | $3.72B | $2.39B | · | $1.21B | $1.19B | $965M | · | $1.21B | $1.10B | $823M | · | $563M | $840M | $900M | · | $240M | |
| P/E | -30.9 | -23.9 | · | -11.1 | -10.0 | -10.2 | · | -14.8 | -13.4 | -10.1 | · | -3.0 | -2.8 | -2.2 | · | -0.9 | |
| P/B | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Tangible Book | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Cash Flow | · | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.2 | · | · | |
| Earnings Yield | -3.2% | -4.2% | · | -9.0% | -10.0% | -9.8% | · | -6.7% | -7.5% | -10.0% | · | -33.9% | -36.2% | -44.9% | · | -111.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M |
| Diluted EPS | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M |
Institutional owners (13F) 219 filers · $3.9B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
219
Value held
$3.9B
New positions
61
Exited positions
17
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 61 (-12 vs prior Q) | 17 (+2 vs prior Q) | 82 (+22 vs prior Q) | 52 (+20 vs prior Q) | +15.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $508,769,634 | 10,025,017 | 13.10% | Shares |
| ORBIMED ADVISORS LLC | $343,914,074 | 6,776,632 | 8.86% | Shares |
| Polar Capital Holdings Plc | $326,354,777 | 6,430,636 | 8.40% | Shares |
| BlackRock, Inc. | $221,254,979 | 4,359,704 | 5.70% | Shares |
| Vestal Point Capital, LP | $203,000,000 | 4,000,000 | 5.23% | Shares |
| Commodore Capital LP | $166,206,250 | 3,275,000 | 4.28% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $130,376,852 | 2,569,002 | 3.36% | Shares |
| CITADEL ADVISORS LLC | $105,001,345 | 2,068,992 | 2.70% | Shares |
| Fairmount Funds Management LLC | $94,173,933 | 1,855,644 | 2.42% | Shares |
| Siren, L.L.C. | $90,051,358 | 1,774,411 | 2.32% | Shares |
| Bellevue Group AG | $75,617,500 | 1,490,000 | 1.95% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $71,430,882 | 1,407,202 | 1.84% | Shares |
| First Light Asset Management, LLC | $69,058,063 | 1,360,750 | 1.78% | Shares |
| STATE STREET CORP | $61,591,012 | 1,213,616 | 1.59% | Shares |
| Pictet Asset Management Holding SA | $58,960,538 | 1,161,784 | 1.52% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $54,978,135 | 1,083,313 | 1.42% | Shares |
| NOVO HOLDINGS A/S | $50,750,000 | 1,000,000 | 1.31% | Shares |
| First Turn Management, LLC | $48,433,770 | 954,360 | 1.25% | Shares |
| SAMLYN CAPITAL, LLC | $46,316,328 | 912,637 | 1.19% | Shares |
| BAKER BROS. ADVISORS LP | $45,938,443 | 905,191 | 1.18% | Shares |
| Candriam S.C.A. | $45,918,733 | 905,674 | 1.18% | Shares |
| Tri Locum Partners LP | $43,985,837 | 866,716 | 1.13% | Shares |
| VANGUARD GROUP INC | $43,145,640 | 2,801,665 | 1.11% | Shares |
| ALLIANCEBERNSTEIN L.P. | $35,129,511 | 896,161 | 0.90% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $34,074,507 | 671,412 | 0.88% | Shares |
| Balyasny Asset Management L.P. | $30,814,842 | 607,189 | 0.79% | Shares |
| AMERICAN CENTURY COMPANIES INC | $28,732,976 | 566,165 | 0.74% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28,560,222 | 562,763 | 0.74% | Shares |
| Avidity Partners Management LP | $27,912,500 | 550,000 | 0.72% | Shares |
| MARSHALL WACE, LLP | $27,012,653 | 532,269 | 0.70% | Shares |
| Venrock Adviser, LLC | $26,711,298 | 526,331 | 0.69% | Shares |
| MORGAN STANLEY | $25,878,866 | 509,928 | 0.67% | Shares |
| Affinity Asset Advisors, LLC | $25,375,000 | 500,000 | 0.65% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $24,836,137 | 489,382 | 0.64% | Shares |
| Logos Global Management LP | $23,598,750 | 465,000 | 0.61% | Shares |
| Rock Springs Capital Management LP | $23,579,719 | 464,625 | 0.61% | Shares |
| NORTHERN TRUST CORP | $22,377,604 | 440,938 | 0.58% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21,540,330 | 424,440 | 0.55% | Shares |
| MILLENNIUM MANAGEMENT LLC | $20,876,622 | 411,362 | 0.54% | Shares |
| Nicholas Investment Partners, LP | $19,870,097 | 391,529 | 0.51% | Shares |
| ADAR1 Capital Management, LLC | $19,676,689 | 387,718 | 0.51% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $19,462,118 | 383,490 | 0.50% | Shares |
| Nuveen, LLC | $18,991,513 | 374,217 | 0.49% | Shares |
| Seven Fleet Capital Management LP | $18,543,340 | 365,386 | 0.48% | Shares |
| Woodline Partners LP | $17,617,457 | 347,142 | 0.45% | Shares |
| STEMPOINT CAPITAL LP | $17,605,886 | 346,914 | 0.45% | Shares |
| UBS Group AG | $17,362,337 | 342,115 | 0.45% | Shares |
| Spruce Street Capital LP | $16,697,055 | 329,006 | 0.43% | Shares |
| GOLDMAN SACHS GROUP INC | $16,349,417 | 322,156 | 0.42% | Shares |
| Longaeva Partners L.P. | $15,862,420 | 312,560 | 0.41% | Shares |
Activists & 5%+ owners 7 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, ORBIMED GENESIS GP LLC, ORBIMED CAPITAL LLC ×7 filings | June 24, 2026 | 9.50% | Amendment | · | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab ×5 filings | July 29, 2024 | · | Initial filing | · | SEC |
| 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab | March 6, 2023 | · | Initial filing | Passive investment | SEC |
| May 24, 2022 | · | Initial filing | · | SEC | |
| New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell, Peter W. Sonsini ×3 filings | April 25, 2022 | · | Initial filing | Passive investment | SEC |
| Arix Bioscience Plc, Arix Bioscience Holdings Limited, Mark Chin ×3 filings | July 20, 2021 | · | Initial filing | Capital structure | SEC |
| Arix Bioscience Plc (2), Arix Bioscience Holdings Limited (2), Mark Chin (1) (2) | March 24, 2020 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 32 insiders · 8 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Richard A. Fair | PRESIDENT AND CEO | Dec. 11, 2025 A | · | 0 | 0 | $0 |
| Samuel Kintz | PRESIDENT AND CEO | Nov. 17, 2025 S | 890,392 | 0 | 2 | $-539,375 |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sept. 17, 2026 M | 38,000 | 0 | 14 | $-1,531,693 |
| Michael Gray | CFO & COO | Feb. 22, 2023 S | 27,610 | 0 | 0 | $0 |
| Anish Patel | CHIEF OPERATING OFFICER | Feb. 12, 2026 A | 20,000 | 0 | 7 | $-1,741,665 |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sept. 17, 2026 M | 25,000 | 0 | 24 | $-5,387,363 |
| Joseph P Lyssikatos | CHIEF SCIENTIFIC OFFICER | Feb. 12, 2026 A | 18,750 | 0 | 11 | $-4,795,279 |
| Kenneth Attie | SVP, CMO | Jan. 28, 2022 A | 34,100 | 0 | 0 | $0 |
| Mika K Derynck | Director | Aug. 4, 2026 M | 0 | 0 | 1 | $-9,561,047 |
| Lori Anne Kunkel | Director | July 6, 2026 S | 41,884 | 0 | 5 | $-850,226 |
| Richard A. Heyman | Director | Feb. 17, 2026 S | 22,647 | 0 | 6 | $-413,427 |
| Rahul D. Ballal | Director | Feb. 12, 2026 A | 22,341 | 0 | 0 | $0 |
| Jake Bauer | Director | Feb. 12, 2026 A | 87,372 | 0 | 0 | $0 |
| Rishi Gupta | Director | Feb. 12, 2026 A | 7,663,349 | 0 | 0 | $0 |
| Scott J. Garland | Director | Feb. 12, 2026 A | · | 0 | 0 | $0 |
| Andrew John Phillips | Director | Feb. 6, 2025 A | · | 0 | 0 | $0 |
| Andrew J. Schwab | Director | Feb. 23, 2023 A | 960,383 | 0 | 0 | $0 |
| Laura A Williams | Director | June 2, 2022 A | · | 0 | 0 | $0 |
| Mark Chin | Director | June 2, 2022 A | 2,344,072 | 0 | 0 | $0 |
| Edward R. Conner | Director | June 2, 2022 A | · | 0 | 0 | $0 |
| Barbara Dalton | Director | June 2, 2022 A | 1,557,722 | 0 | 0 | $0 |
| David P Bonita | Director | June 2, 2022 A | 4,199,068 | 0 | 0 | $0 |
| David M Mott | Director | June 2, 2022 A | 229,224 | 0 | 0 | $0 |
| Carl Goldfischer | Director | June 2, 2022 A | · | 0 | 0 | $0 |
| James G Mcarthur | Director | March 16, 2020 A | · | 0 | 0 | $0 |
| Mette Kirstine Agger | Director | March 16, 2020 A | 1,432,722 | 0 | 0 | $0 |
| COMMODORE CAPITAL LP | 10% owner | Feb. 23, 2023 J | 1,448,640 | 0 | 0 | $0 |
| Leonard Braden Michael | 10% owner | Jan. 3, 2023 S | 1,767,774 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10% owner | March 16, 2020 C | 293,013 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10% owner | March 16, 2020 C | 1,432,722 | 0 | 0 | $0 |
| H LUNDBECK A S | 10% owner | March 16, 2020 C | 522,499 | 0 | 0 | $0 |
| Sara M. Nayeem | · | June 29, 2021 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 37 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.68% | 6,348 NS | July 31, 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.36% | 108,581 SH | Oct. 1, 2026 | Daily |
| BBC · ETFis Series Trust I | 0.80% | 6,738 NS | July 31, 2026 | N-PORT |
| IHE · iShares Trust | 0.70% | 201,628 SH | Sept. 11, 2026 | Daily |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.42% | 37,595 SH | Oct. 1, 2026 | Daily |
| ESSC · Strategy Shares | 0.29% | 1,904 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.23% | 423,426 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.22% | 5,185 SH | Oct. 1, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.19% | 52,888 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.16% | 403,282 SH | Sept. 11, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.14% | 32,681 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.13% | 45,928 SH | Aug. 19, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 15,322 NS | July 31, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.12% | 47,349 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.08% | 1,096,839 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.08% | 20,481 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.07% | 12,063 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 246,533 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.07% | 33,273 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.06% | 174,090 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.04% | 141,971 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 22,459 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 624,513 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.02% | 2,922 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 11,582 SH | Oct. 1, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.01% | 3,866 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 569 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 1,738 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 66,937 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 12,166 SH | Sept. 10, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 7,755 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 28,939 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 8,619 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,883,832 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,533 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 2,544 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 4,092 SH | Sept. 11, 2026 | Daily |
ELVN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 20 analysts
BUY
Median target
$74.00
+57.5%
8 40.0%
Strong Buy
11 55.0%
Buy
1 5.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-28Mean target $73.90 +57.3%
← Below all targets
Current price $46.97
Low$64.00
Mean$73.90
High$82.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ELVN | $915M | -8.4 | · | · | -21.9% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| AMLX | $1.33B | -7.9 | -77.1% | · | -61.2% | · |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | · |
| MBX | $1.42B | -13.3 | · | · | -29.6% | · |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026